Open Access 01-12-2015 | Research Highlight
Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting—its impact on clinical practice
Published in: Journal of Hematology & Oncology | Issue 1/2015
Login to get access